Connection

Co-Authors

This is a "connection" page, showing publications co-authored by YUNYUN CHEN and STEPHEN YENZEN LAI.
Connection Strength

0.682
  1. Regulation of receptor tyrosine kinases by miRNA: overexpression of miRNA using lentiviral inducible expression vectors. Methods Mol Biol. 2015; 1233:135-47.
    View in: PubMed
    Score: 0.127
  2. Evaluation of hyperpolarized [1-??C]-pyruvate by magnetic resonance to detect ionizing radiation effects in real time. PLoS One. 2014; 9(1):e87031.
    View in: PubMed
    Score: 0.119
  3. Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget. 2013 Sep; 4(9):1388-98.
    View in: PubMed
    Score: 0.116
  4. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther. 2012 Jun; 11(6):1373-80.
    View in: PubMed
    Score: 0.106
  5. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91.
    View in: PubMed
    Score: 0.097
  6. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
    View in: PubMed
    Score: 0.034
  7. Development and characterization of six new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab. 2015 Feb; 100(2):E243-52.
    View in: PubMed
    Score: 0.032
  8. Src inhibitors in suppression of papillary thyroid carcinoma growth. Head Neck. 2014 Mar; 36(3):375-84.
    View in: PubMed
    Score: 0.028
  9. MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo. Mol Cancer Ther. 2010 Jul; 9(7):1968-76.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.